Neonatal epilepsy and inborn errors of metabolism;Épilepsies néonatales et erreurs innées du métabolisme

Archives de Pediatrie

Volumn 13, Issue 3, 2006, Pages 284-292

  Bahi Buisson, N ^a,b   Mention, K ^a   Leger P L ^a   Valayanopoulos, V ^a   Nabbout, R ^a,b   Kaminska, A ^c   Plouin, P ^a   Dulac, O ^a,b   De Lonlay, P ^a   Desguerre, I ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c NONE   (France)

Author keywords

Convulsions; Epilepsy; Infant; Metabolic diseases; Myoclonic; Newborn

Indexed keywords

ADENYLOSUCCINATE LYASE; ANTICONVULSIVE AGENT; DIAZEPAM; FOLINIC ACID; GLUCOSE TRANSPORTER 1; PHENOBARBITAL; PYRIDOXAMINE PHOSPHATE OXIDASE; PYRIDOXINE; SERINE; SUCCINATE SEMIALDEHYDE DEHYDROGENASE; VALPROIC ACID; VIGABATRIN; 4 AMINOBUTYRIC ACID; BIOTIN; VITAMIN B COMPLEX;

ALERTNESS; BRAIN DISEASE; CONVULSION; DISORDERS OF CARBOHYDRATE METABOLISM; ELECTROENCEPHALOGRAPHY; ELECTROGRAPHY; EPILEPSY; HUMAN; HYPERAMMONEMIA; HYPERGLYCEMIA; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; REVIEW; AGE; BRAIN; CLASSIFICATION; COMPARATIVE STUDY; METABOLISM; MYOCLONUS EPILEPSY; NEWBORN; SEIZURE; TIME;

AGE FACTORS; ANTICONVULSANTS; BIOTIN; BRAIN; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT, NEWBORN; LEUCOVORIN; METABOLISM, INBORN ERRORS; PYRIDOXINE; SEIZURES; TIME FACTORS; VITAMIN B COMPLEX;

EID: 33644501104     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2005.10.024     Document Type: Short Survey

References (37)

1. B. Dalla Bernardina, O. Dulac, and N. Fejerman Early myoclonic epileptic encephalopathy (E.M.E.E.) Eur. J. Pediatr. 140 1983 248 252
2. P. Baxter Pyridoxine-dependent seizures: a clinical and biochemical conundrum Biochim. Biophys. Acta 1647 2003 36 41
3. P.B. Mills, R.A. Surtees, and M.P. Champion Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase Hum. Mol. Genet. 14 2005 1077 1086
4. A.D. Hunt Jr., J. Stokes Jr., and W.W. Mc Crory Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine Pediatrics 13 1954 140 145
5. P. Baxter Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK Arch. Dis. Child. 81 1999 431 433
6. P. Baxter, P. Griffiths, and T. Kelly Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient Dev. Med. Child Neurol. 38 1996 998 1006
7. R. Nabbout, C. Soufflet, and P. Plouin Pyridoxine dependent epilepsy: a suggestive electroclinical pattern Arch. Dis. Child. Fetal Neonatal Ed. 81 1999 F125 F129
8. P. Clayton, R.A. Surtees, and C. DeVile Neonatal epileptic encephalopathy Lancet 361 2003 1614
9. M.F. Kuo, and H.S. Wang Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine Pediatr. Neurol. 26 2002 146 147
10. O.A. Torres, V.S. Miller, and N.M. Buist Folinic acid-responsive neonatal seizures J. Child Neurol. 14 1999 529 532
11. K. Hyland, and L.A. Arnold Value of lumbar puncture in the diagnosis of infantile epilepsy and folinic acid-responsive seizures J. Child Neurol. 17 Suppl. 3 2002 3S48 3S55 (discussion 3S56)
12. J.E. Collins, N.S. Nicholson, and N. Dalton Biotinidase deficiency: early neurological presentation Dev. Med. Child Neurol. 36 1994 268 270
13. B.A. Salbert, J.M. Pellock, and B. Wolf Characterization of seizures associated with biotinidase deficiency Neurology 43 1993 1351 1355
14. G. Seidner, M.G. Alvarez, and J.I. Yeh GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier Nat. Genet. 18 1998 188 191
15. K. Brockmann, D. Wang, and C.G. Korenke Autosomal dominant glut-1 deficiency syndrome and familial epilepsy Ann. Neurol. 50 2001 476 485
16. A. Von Moers, K. Brockmann, and D. Wang EEG features of glut-1 deficiency syndrome Epilepsia 43 2002 941 945
17. J. Klepper, M. Garcia-Alvarez, and K.R. O'Driscoll Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter protein syndrome J. Clin. Lab. Anal. 13 1999 116 121
18. J. Klepper, A. Florcken, and J. Fischbarg Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro Eur. J. Pediatr. 162 2003 84 89
19. J. Jaeken Genetic disorders of gamma-aminobutyric acid, glycine, and serine as causes of epilepsy J. Child Neurol. 17 Suppl. 3 2002 3S84 3S87 (discussion 3S88)
20. T.J. de Koning, and L.W. Klomp Serine-deficiency syndromes Curr. Opin. Neurol. 17 2004 197 204
21. R.N. Auer Hypoglycemic brain damage Metab. Brain Dis. 19 2004 169 175
22. B.R. Tharp Unique EEG pattern (comb-like rhythm) in neonatal maple syrup urine disease Pediatr. Neurol. 8 1992 65 68
23. D.A. Applegarth, and J.R. Toone Glycine encephalopathy (nonketotic hyperglycinaemia): review and update J. Inherit. Metab. Dis. 27 2004 417 422
24. A.M. Thomson Glycine is a coagonist at the NMDA receptor/channel complex Prog. Neurobiol. 35 1990 53 74
25. A. Hamosh, J.F. Maher, and G.A. Bellus Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia J. Pediatr. 132 1998 709 713
26. J. Jaeken, L. Corbeel, and P. Casaer Dipropylacetate (valproate) and glycine metabolism Lancet 2 1977 617
27. A.B. Dublin, J.K. Hald, and S.L. Wootton-Gorges Isolated sulfite oxidase deficiency: MR imaging features AJNR Am. J. Neuroradiol. 23 2002 484 485
28. H.M. Slot, W.C. Overweg-Plandsoen, and H.D. Bakker Molybdenum-cofactor deficiency: an easily missed cause of neonatal convulsions Neuropediatrics 24 1993 139 142
29. G.L. Arnold, C.L. Greene, and J.P. Stout Molybdenum cofactor deficiency J. Pediatr. 123 1993 595 598
30. M. Castro, C. Perez-Cerda, and B. Merinero Screening for adenylosuccinate lyase deficiency: clinical, biochemical and molecular findings in four patients Neuropediatrics 33 2002 186 189
31. G. Van den Berghe, M.F. Vincent, and J. Jaeken Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency J. Inherit. Metab. Dis. 20 1997 193 202
32. P.L. Pearl, K.M. Gibson, and M.T. Acosta Clinical spectrum of succinic semialdehyde dehydrogenase deficiency Neurology 60 2003 1413 1417
33. A. Gropman Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency Ann. Neurol. 54 Suppl. 6 2003 S66 S72
34. A.J. Barkovich, and W.W. Peck MR of Zellweger syndrome AJNR Am. J. Neuroradiol. 18 1997 1163 1170
35. Y. Takahashi, Y. Suzuki, and K. Kumazaki Epilepsy in peroxisomal diseases Epilepsia 38 1997 182 188
36. P.K. Grewal, and J.E. Hewitt Glycosylation defects: a new mechanism for muscular dystrophy? Hum. Mol. Genet. 12 Spec No:2 2003 R259 R264
37. N.R. Buist, O. Dulac, and T. Bottiglieri Metabolic evaluation of infantile epilepsy: summary recommendations of the Amalfi Group J. Child Neurol. 17 Suppl. 3 2002 3S98 3S102